| 玻璃体内注射清栓酶治疗实验性玻璃体积血 |
| |
| 引用本文： | 陈梅珠,周国筠.玻璃体内注射清栓酶治疗实验性玻璃体积血[J].蛇志,1993,5(2):2-5. |
| |
| 作者姓名： | 陈梅珠 周国筠 |
| |
| 作者单位： | 广州第一军医大学南方医院眼科 510515 |
| |
| 摘 要： | 清栓酶可促进玻璃体内纤维蛋白凝血块溶解,我们制作新鲜及陈旧性兔眼玻璃体积血模型,将清栓酶、尿激酶及注射用水分别注入玻璃体腔内,观察眼底、测定玻璃体出血指数、FDP含量、进行3P 试验,结果发现清栓酶有治疗效果,同对照组相比统计学上有显著差异,同尿激酶相比无差异,且未发现有毒副作用。
|
| 关 键 词： | 清栓酶 尿激素 玻璃体积血 疗效 |
INTERAVITREAL SVATE TREATEMENT OF EXPERIMENTAL VITREOUS HEMORRHAGE |
| |
| Chen Meizhu Zhou Guojun.INTERAVITREAL SVATE TREATEMENT OF EXPERIMENTAL VITREOUS HEMORRHAGE[J].Journal of Snake,1993,5(2):2-5. |
| |
| Authors: | Chen Meizhu Zhou Guojun |
| |
| Abstract: | Svate can promote rapid resolution of intraocular fibrin clots.We produced fresh and old models of vitreous hemorrhage.The efficacy of intravitrcal svate in promoting the shortterm clear- anec of vitreous hemorrhage was investigated by ophthahnoscopy,vitreous hemorrhage index, vitreous concentration of fibrin(ogcn)degradation product(FDP)and 3P experiment.Three treat- ment groups of Svate,Urokinase and control were studied.The Svate and UK group showed a statistically significant difference as compared with control group,respectively.However,there was no statistical difference in Svate and,UK group.No evidence of toxicity was observed in Svate group. |
| |
| Keywords: | Svate Urokinase Vitreous Hemorrhage |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
